Side effects such as muscle loss and nutritional imbalance have been reported with long-term use of glucagon-like peptide-1 ...

DEATHS from liver cancer – one of the fastest growing forms of the disease – have surged by 50 per cent in just two decades.

Glucagon-like peptide-1 (GLP-1) receptor agonists may improve cardiovascular outcomes in the year following TAVI for aortic ...

A new study has found that 11 types of cancer are on the rise in the 20 to 49-year-old age group, with obesity emerging as a ...

Nearly 15% of acute coronary syndromes in Northern California are methamphetamine-related, which remains a strong predictor of poor survival in a population of predominantly young men, researchers ...

Orforglipron is a new oral GLP-1 drug that outperforms oral semaglutide in blood sugar control and weight loss while offering ...

Obesity is an important driver of rising cancer rates among the under-50s, a major new study suggests.While it does not ...

Is your waist circumference or your body weight a better indicator of your health risks? Learn the difference between these ...

Obesity might be to blame for part of the increase in cancer among young people, a study in the UK has found, but the causes ...

Food noise is a genuine phenomenon characterized by a constant preoccupation with food. The causes of food noise are complex ...

Before the rise of GLP-1s, obesity experts didn’t study the internal buzz that compels people to eat. Now that food noise is ...

People who live with obesity are 'tagging' a memory of being overweight on a key part of the immune system - leaving people ...